Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) EBT Margin (2023)

Historic EBT Margin for Contineum Therapeutics (CTNM) over the last 1 years, with Q2 2023 value amounting to 84.6%.

  • Contineum Therapeutics' EBT Margin changed N/A to 84.6% in Q2 2023 from the same period last year, while for Mar 2024 it was 39.17%, marking a year-over-year change of. This contributed to the annual value of 46.34% for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2023, Contineum Therapeutics' EBT Margin is 84.6%.
  • In the past 5 years, Contineum Therapeutics' EBT Margin registered a high of 5243.48% during Q1 2023, and its lowest value of 84.6% during Q2 2023.